共 50 条
- [31] Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast CancerMOLECULAR CANCER THERAPEUTICS, 2019, 18 (12) : 2220 - 2232Kietzman, William B.Graham, Garrett T.Ory, VirginieSharif, Ghada M.Kushner, Max H.Gallanis, Gregory T.Kallakury, BhaskarWellstein, AntonRiegel, Anna T.
- [32] Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerNature Communications, 11Jennifer Y. GeShaokun ShuMijung KwonBojana JovanovićKatherine MurphyAnushree GulvadyAnne FasslAnne TrinhYanan KuangGrace A. HeaveyAdrienne LuomaCloud PaweletzAaron R. ThornerKai W. WucherpfennigJun QiMyles BrownPiotr SicinskiThomas O. McDonaldDavid PellmanFranziska MichorKornelia Polyak
- [33] Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerNATURE COMMUNICATIONS, 2020, 11 (01)Ge, Jennifer Y.Shu, ShaokunKwon, MijungJovanovi, BojanaMurphy, KatherineGulvady, AnushreeFassl, AnneTrinh, AnneKuang, YananHeavey, Grace A.Luoma, AdriennePaweletz, CloudThorner, Aaron R.Wucherpfennig, Kai W.Qi, JunBrown, MylesSicinski, PiotrMcDonald, Thomas O.Pellman, DavidMichor, FranziskaPolyak, Kornelia
- [34] Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast CancerCLINICAL CANCER RESEARCH, 2022, 28 (10) : 2167 - 2179Vigano, LuciaLocatelli, AlbertaUlisse, AdeleGalbardi, BarbaraDugo, MatteoTosi, DiegoTacchetti, CarloDaniele, TizianaGyorffy, BalazsSica, LorenzoMacchini, MarinaZambetti, MilviaZambelli, StefaniaBianchini, GiampaoloGianni, Luca
- [35] Combination mTORC1/2 and BCL- XL inhibition in endocrine and CDK4/6-resistant estrogen receptor-positive breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Sammons, SarahAnderson, GraceWardell, SuzanneMcDonnell, Donald P.Marcom, Paul KellyWood, Kris
- [36] Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancerONCOTARGET, 2017, 8 (08) : 12558 - 12575McDermott, Martina S. J.Chumanevich, Alexander A.Lim, Chang-ukLiang, JiaxinChen, MengqianAltilia, SerenaOliver, DavidRae, James M.Shtutman, MichaelKiaris, HippokratisGyorffy, BalazsRoninson, Igor B.Broude, Eugenia V.
- [37] Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to PaclitaxelJOURNAL OF CANCER, 2016, 7 (08): : 947 - 956Trape, Adriana PriscilaLiu, ShuyingCortes, Andrea CarolinaUeno, Naoto T.Gonzalez-Angulo, Ana Maria
- [38] A 'real world' experience of CDK4/6 inhibition with ribociclib and endocrine therapy in hormone receptor positive metastatic breast cancer in AustraliaCANCER RESEARCH, 2020, 80 (04)Lok, Sheau WenBaron-Hay, SallyLim, ElgeneBlum, RobertBoyle, FranClarke, KerrieCuff, KatharineGreen, MichaelMalik, LaeeqMok, KellyMurray, NickNott, LouiseNottage, MichelleTafreshi, AliTsoi, DaphneYeo, BelindaGibbs, PeterDe Boer, Richard
- [39] Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast cancerBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):Zheng, YangZhang, ZeyuanLi, DanHuang, RongNing, Shipeng
- [40] Willingness of women with early estrogen receptor-positive breast cancer to take adjuvant CDK4/6 inhibitorsCURRENT ONCOLOGY, 2020, 27 (03) : 127 - 134Lipton, N. J.Jesin, J.Warner, E.Cao, X.Kiss, A.Desautels, D.Jerzak, K. J.